Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Aura Biosciences (AURA) Shares Issued (2020 - 2026)

Aura Biosciences filings provide 7 years of Shares Issued readings, the most recent being $123000.0 for Q1 2026.

  • Quarterly Shares Issued changed N/A to $123000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$21.6 million through Mar 2026, down 113984.21% year-over-year, with the annual reading at $6.7 million for FY2025, 3685.31% up from the prior year.
  • Shares Issued hit $123000.0 in Q1 2026 for Aura Biosciences, up from -$39.8 million in the prior quarter.
  • Across five years, Shares Issued topped out at $14.2 million in Q2 2025 and bottomed at -$39.8 million in Q4 2025.
  • Average Shares Issued over 5 years is -$1.2 million, with a median of $158000.0 recorded in 2024.
  • Peak annual rise in Shares Issued hit 9059.49% in 2025, while the deepest fall reached 5604.44% in 2025.
  • Aura Biosciences' Shares Issued stood at $104000.0 in 2022, then skyrocketed by 2104.81% to $2.3 million in 2023, then plummeted by 130.44% to -$698000.0 in 2024, then tumbled by 5604.44% to -$39.8 million in 2025, then soared by 100.31% to $123000.0 in 2026.
  • Per Business Quant, the three most recent readings for AURA's Shares Issued are $123000.0 (Q1 2026), -$39.8 million (Q4 2025), and $3.9 million (Q3 2025).